Veloxis Pharmaceuticals A/S
Warrant Programme – New Articles of Association

DGAP-News: Veloxis Pharmaceuticals A/S

17.11.2014 / 11:53

---------------------------------------------------------------------

Company Announcement no. 26/2014



To: NASDAQ OMX Copenhagen A/S                                 Hørsholm,
Denmark, 17 November 2014 



                Warrant Programme - New Articles of Association



In accordance with its authorisation pursuant to Section 5A of the Articles of
Association, the Board of Directors of Veloxis Pharmaceuticals A/S has on 12
November issued 300,000 warrants for the subscription of nominally DKK 30,000
shares in the Company. 

The amendment of the Articles of Association associated with the issue of
warrants has today been registered with the Danish Business Authority. The new
Articles of Association are for Veloxis Pharmaceuticals A/S are attached. 



For more information, please contact:



Veloxis Pharmaceuticals A/S



Bill Polvino                                            Johnny Stilou

President & CEO                                    EVP, Chief Financial Officer

Mobile: +1 917 647 9107                      Mobile: +45 21 227 227

Email: wjp@veloxis.com                        Email: jst@veloxis.com



About Veloxis Pharmaceuticals

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis
Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company.
Veloxis' unique, patented delivery technology, MeltDose(R), is designed to
enhance the absorption and bioavailability of select orally administered drugs.
Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX:
VELO. 

For further information, please visit www.veloxis.com.
News Source: NASDAQ OMX



---------------------------------------------------------------------

17.11.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                      
Company:     Veloxis Pharmaceuticals A/S  
 
 
             Denmark                      
ISIN:        DK0060048148                 
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
297546 17.11.2014